• British Pharmacopoeia Volume IV
  • Herbal Drugs, Herbal Drug Preparations and Herbal Medicinal Products

Refined and Quantified Ginkgo Dry Extract

European Union chaplet of stars
scroll to previous hit
scroll to next hit
General Notices

(Ph. Eur. monograph 1827)

Ph Eur

DEFINITION

Refined and quantified dry extract produced from Ginkgo leaf (1828).

Content:
  • flavonoids, expressed as flavone glycosides (Mr 756.7): 22.0 per cent to 27.0 per cent (dried extract);
  • bilobalide: 2.6 per cent to 3.2 per cent (dried extract);
  • ginkgolides A, B and C: 2.8 per cent to 3.4 per cent (dried extract);
  • ginkgolic acids: maximum 5 ppm (dried extract).
PRODUCTION

The extract is produced from the herbal drug by an appropriate procedure using organic solvents and their mixtures with water, physical separation steps as well as other suitable processes.

CHARACTERS
Appearance

Bright yellow-brown, powder or friable mass.

IDENTIFICATION

Thin-layer chromatography (2.2.27).

Test solution  Dissolve 20.0 mg of the extract to be examined in 10 mL of a mixture of 2 volumes of water R and 8 volumes of methanol R.

Reference solution  Dissolve 1.0 mg of chlorogenic acid R and 3.0 mg of rutin R in 20 mL of methanol R.

Plate  TLC silica gel plate R (5-40 µm) or [TLC silica gel plate R (2-10 µm)].

Mobile phase  anhydrous formic acid R, glacial acetic acid R, water R, ethyl acetate R (7.5:7.5:17.5:67.5 V/V/V/V).

Application  20 µL [or 5 µL], as bands.

Development  Over a path of 17 cm [or 6 cm].

Drying  At 100-105 °C.

Detection  Spray the plate whilst still hot with a 10 g/L solution of diphenylboric acid aminoethyl ester R in methanol R, then spray with a 50 g/L solution of macrogol 400 R in methanol R; allow to dry in air for about 30 min and examine in ultraviolet light at 365 nm.

Results  See below the sequence of zones present in the chromatograms obtained with the reference solution and the test solution. Furthermore, other, weaker fluorescent zones may be present in the chromatogram obtained with the test solution.

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_1_2012_70_tb.png


ASSAY
Flavonoids

Liquid chromatography (2.2.29).

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_2_2012_70_fig.png


Test solution  Dissolve 0.200 g of the extract to be examined in 20 mL of methanol R. Add 15.0 mL of dilute hydrochloric acid R and 5 mL of water R and dilute to 50.0 mL with methanol R. Transfer 10.0 mL of this solution into a 10 mL brown-glass vial. Close the vial with a tight rubber membrane stopper and secure with an aluminium crimped cap. Heat on a water-bath for 25 min. Allow to cool to 20 °C.

Reference solution  Dissolve 10.0 mg of quercetin dihydrate CRS in 20 mL of methanol R. Add 15.0 mL of dilute hydrochloric acid R and 5 mL of water R and dilute to 50.0 mL with methanol R.

Column:
  • sizel = 0.125 m, Ø = 4 mm;
  • temperature: 25 °C.
Mobile phase:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_3_2012_70_tb.png


Flow rate  1.0 mL/min.

Detector  Spectrophotometer at 370 nm.

Injection  10 µL.

Relative retention  With reference to quercetin (retention time = about 12.5 min): kaempferol = about 1.4; isorhamnetin = about 1.5.

System suitability  Test solution:

  • resolution: minimum 1.5 between the peaks due to kaempferol and isorhamnetin.

Determine the sum of the areas including all the peaks from the peak due to quercetin to the peak due to isorhamnetin in the chromatogram obtained with the test solution (see Figure 1827.-1).

Calculate the percentage content of flavonoids, expressed as flavone glycosides, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_4_2012_70_eq.png


F 1

=

sum of the areas of all the peaks from the peak due to quercetin to the peak due to isorhamnetin in the chromatogram obtained with the test solution

F 2

=

area of the peak due to quercetin in the chromatogram obtained with the reference solution

m 1

=

mass of quercetin dihydrate CRS in the reference solution, in grams

m 2

=

mass of the extract to be examined used to prepare the test solution, in grams

p

=

percentage content of anhydrous quercetin in quercetin dihydrate CRS.

Terpene lactones

Liquid chromatography (2.2.29).

Test solution  Place 0.120 g of the extract to be examined in a 25 mL beaker and dissolve it in 10 mL of phosphate buffer solution pH 5.8 R by stirring. Transfer the solution into a chromatography column, about 0.15 m long and about 30 mm in internal diameter, containing 15 g of kieselguhr for chromatography R. Wash the beaker with 2 quantities, each of 5 mL, of phosphate buffer solution pH 5.8 R and transfer the washings to the chromatography column. Allow to stand for 15 min. Elute with 100 mL of ethyl acetate R. Evaporate the eluate to dryness at a pressure not exceeding 4 kPa in a water-bath at 50 °C. The residue of solvent is eliminated by an air-current. Take up the residue in 2.5 mL of the mobile phase.

Reference solution (a)  Dissolve 30.0 mg of benzyl alcohol CRS in the mobile phase and dilute to 100.0 mL with the mobile phase.

Reference solution (b)  Place 0.120 g of the ginkgo dry extract for peak identification CRS in a 25 mL beaker and dissolve it in 10 mL of phosphate buffer solution pH 5.8 R by stirring, then proceed as described for the test solution.

Column:
  • sizel = 0.25 m, Ø = 4 mm;
  • temperature: 25 °C.

Mobile phase  tetrahydrofuran R, methanol R, water R (10:20:75 V/V/V).

Flow rate  1.0 mL/min.

Detection  Refractometer maintained at 35 °C.

Injection  100 µL.

Identification of peaks  Use the chromatogram supplied with ginkgo dry extract for peak identification CRS and the chromatogram obtained with the reference solution (b) to identify the peaks due to bilobalide and ginkgolides A, B and C.

System suitability:

Calculate the percentage content of bilobalide, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_5_2012_70_eq.png


Calculate the percentage content of ginkgolide A, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_6_2012_70_eq.png


Calculate the percentage content of ginkgolide B, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_7_2012_70_eq.png


Calculate the percentage content of ginkgolide C, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_8_2012_70_eq.png


F 1

=

area of the peak due to bilobalide in the chromatogram obtained with the test solution

F 2

=

area of the peak due to ginkgolide A in the chromatogram obtained with the test solution

F 3

=

area of the peak due to ginkgolide B in the chromatogram obtained with the test solution

F 4

=

area of the peak due to ginkgolide C in the chromatogram obtained with the test solution

F 5

=

area of the peak due to benzyl alcohol in the chromatogram obtained with reference solution (a)

m 1

=

mass of benzyl alcohol CRS in reference solution (a), in grams

m 2

=

mass of the extract to be examined used to prepare the test solution, in grams

p

=

percentage content of benzyl alcohol in benzyl alcohol CRS.

Calculate the percentage content of the sum of ginkgolides A, B and C, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_9_2012_70_eq.png


G A

=

percentage content of ginkgolide A

G B

=

percentage content of ginkgolide B

G C

=

percentage content of ginkgolide C.

Ginkgolic acids

Liquid chromatography (2.2.29).

Test solution  Dissolve 0.500 g of the powdered extract to be examined in 8 mL of methanol R, sonicating if necessary, and dilute to 10.0 mL with the same solvent. Centrifuge if necessary.

Reference solution  Dissolve 10.0 mg of ginkgolic acids CRS in 8 mL of methanol R, sonicating if necessary, and dilute to 10.0 mL with the same solvent. Dilute 2.0 mL of this solution to 10.0 mL with methanol R.

Column:
  • sizel = 0.25 m, Ø = 4.6 mm;
  • temperature: 35 °C.
Mobile phase:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_10_2012_70_tb.png


Flow rate  1.0 mL/min.

Detection  Spectrophotometer at 210 nm.

Injection  50 µL.

Identification of components  Use the chromatogram supplied with ginkgolic acids CRS and the chromatogram obtained with the test solution to identify the peaks due to ginkgolic acids C13, C15 and C17.

System suitability  Reference solution:

  • resolution: minimum 2.0 between the peaks due to ginkgolic acids C13 and C15;
  • symmetry factor: 0.8 to 2.0 for the peaks due to ginkgolic acids C13, C15 and C17.

Calculate the content in parts per million of ginkgolic acids expressed as ginkgolic acid C17, using the following expression:

bp2013_v4_28_07_herbal_drug_2 ginkgodryextractrefinedandquantified_11_2012_70_eq.png


A 1

=

sum of the areas of the peaks due to the ginkgolic acids C13, C15 and C17 in the chromatogram obtained with the test solution

A 2

=

area of the peak due to ginkgolic acid C17 in the chromatogram obtained with the reference solution

m 1

=

mass of the extract to be examined used to prepare the test solution, in grams

m 2

=

mass of ginkgolic acids CRS used to prepare the reference solution, in grams

p

=

percentage content of ginkgolic acid C17 in ginkgolic acids CRS.

Ph Eur